Maripau Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Maripau Wealth Management's LLY Position: Q2 2026 in Review
Maripau Wealth Management reduced its Eli Lilly (LLY) stake by 7.3% in Q2 2026, selling an estimated $30.7K and leaving 381 shares worth $457K. The position accounts for 0.16% of the portfolio, ranked #103.
Maripau Wealth Management first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. The position peaked at $474K in Q4 2025. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Maripau Wealth Management held 381 shares of Eli Lilly worth $457K as of Q2 2026.
- Maripau Wealth Management sold 30 Eli Lilly shares in Q2 2026, an estimated $30.7K.
- Eli Lilly made up 0.16% of Maripau Wealth Management's portfolio in Q2 2026, its #103 holding.
- Maripau Wealth Management first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
- Maripau Wealth Management's Eli Lilly position peaked at $474K in Q4 2025.
- 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Maripau Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.